Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols Jan 13, 2025 10:00AM
Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga Dec 4, 2024 02:30AM
Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors Nov 8, 2024 03:54PM
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group Jun 18, 2024 07:30AM
Grifols closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S. Oct 1, 2020 12:13PM


Jul 20, 2020 02:39AM Grifols to acquire Green Cross plasma fractionation facility in Montreal and a plasma collection organization in the U.S. for US$460 million
Jan 31, 2017 04:05PM Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million